topSkip to main content

Menu, Secondary

Menu Trigger

Menu

University of Minnesota, Twin Cities

A new study led by an Iowa State University scientist details the structure of a critical enzyme that enables the coronavirus to resist antiviral medications. Scientists could use the study to find ways to inhibit the enzyme, possibly leading to more effective treatments.
The U.S. Food and Drug Administration (FDA) authorized the production and use of a low-cost ventilator called Coventor first conceived by a team of University of Minnesota researchers
The University of Minnesota has launched two clinical trials to test the drug hydroxychloroquine. One trial examines the drug's effectiveness in preventing COVID-19 disease.
Minnesota researchers orchestrated the state’s fastest on-site testing for COVID-19
A University of Minnesota team, led by researcher Fang Li, studied how mutations that changed the structure of a SARS-CoV-2 protein enabled it to attach more securely to human cells than its predecessor, infect human cells better, and spread faster.
U of M is running a trial using a combination protein that bridges an immune cell and a tumor cell to drive tumor cell killing power exponentially
A team of University of Minnesota researchers have been using a new technology developed by the Swedish company Olink to improve ovarian cancer screening
Researchers at the University of Minnesota have developed a unique 3D-printed transparent skull implant for mice that provides an opportunity to watch activity of the entire brain surface in real time.
In a study with mice, University of Minnesota Medical School researchers have shown that a natural product found in many fruits and vegetables has significant positive effects on health and lifespan.
Researchers from the University of Minnesota (UMN) have developed a method to screen and identify harmful or antibiotic-resistant bacteria within one hour using a portable luminometer.